Xu, T., Yang, Q., Wu, D., Li, C. (2025). A prospective clinical study on the combination of anti-PD1 monoclonal antibody with lenalidomide and azacitidine for the treatment of relapsed/refractory peripheral T-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-780